Pediatric pulmonary hypertension: insulin-like growth factor-binding protein 2 is a novel marker associated with disease severity and survival.
Griffiths, M; Yang, J; Nies, M; Vaidya, D; Brandal, S; Williams, M; Matsui, EC; Grant, T; Damico, R; Ivy, D; et al.
Pediatric Research.
2020;
88:850-856.
Insulin-like growth factor binding protein-2: A new circulating indicator of pulmonary arterial hypertension severity and survival.
Yang, J; Griffiths, M; Nies, MK; Brandal, S; Damico, R; Vaidya, D; Tao, X; Simpson, CE; Kolb, TM; Mathai, SC; et al.
BMC Medicine.
2020;
18.
Elevated Interleukin-6 Levels Predict Clinical Worsening in Pediatric Pulmonary Arterial Hypertension.
Chen, JY; Griffiths, M; Yang, J; Nies, MK; Damico, RL; Simpson, CE; Vaidya, RD; Brandal, S; Ivy, DD; Austin, ED; et al.
The Journal of Pediatrics.
2020;
223:164-169.e1.
Novel mutations and decreased expression of the epigenetic regulator TET2 in pulmonary arterial hypertension.
Potus, F; Pauciulo, MW; Cook, EK; Zhu, N; Hsieh, A; Welch, CL; Shen, Y; Tian, L; Lima, P; Mewburn, J; et al.
Circulation.
2020;
141:1986-2000.
Genetic Admixture and Survival in Diverse Populations with Pulmonary Arterial Hypertension.
Karnes, JH; Wiener, H; Wiener, HW; Schwantes-An, T; Natarajan, B; Sweatt, AJ; Chaturvedi, A; Arora, AH; Arora, A; Batai, K; et al.
American Journal of Respiratory and Critical Care Medicine.
2020;
201:1407-1415.
Noninvasive Prognostic Biomarkers for Left-Sided Heart Failure as Predictors of Survival in Pulmonary Arterial Hypertension.
Simpson, CE; Damico, RL; Hassoun, PM; Martin, LJ; Yang, J; Nies, MK; Vaidya, RD; Brandal, S; Pauciulo, MW; Austin, ED; et al.
Chest.
2020;
157:1606-1616.
Cellular sources of IL-6 and associations with clinical phenotypes and outcomes in PAH.
Simpson, CE; Chen, JY; Damico, RL; Hassoun, PM; Martin, LJ; Yang, J; Nies, M; Griffiths, M; Vaidya, RD; Brandal, S; et al.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology.
2020;
55:1901761-1901761.
Novel risk genes and mechanisms implicated by exome sequencing of 2572 individuals with pulmonary arterial hypertension.
Zhu, N; Pauciulo, MW; Welch, CL; Lutz, KA; Coleman, AW; Gonzaga-Jauregui, C; Wang, J; Grimes, JM; Martin, LJ; He, H; et al.
Genome Medicine: medicine in the post-genomic era.
2019;
11.
Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and paediatric pulmonary hypertension.
Galambos, C; Mullen, MP; Shieh, JT; Schwerk, N; Kielt, MJ; Ullmann, N; Boldrini, R; Stucin-Gantar, I; Haass, C; Bansal, M; et al.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology.
2019;
54:1801965-1801965.
United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implications.
Elliott, CG; Austin, ED; Badesch, D; Badlam, J; Benza, RL; Chung, WK; Farber, HW; Feldkircher, K; Frost, AE; Poms, AD; et al.
Pulmonary Circulation.
2019;
9:2045894019851696-204589401985169.